An experimental Alzheimers medication that is undergoing clinical trials was also found to have a major impact on aggressive brain tumors (malignant gliomas).
Apparently the Alzheimerrs medication works to stop protein from being shut off in the brain and this same switch also stops the spread of the cancer (which was thriving as the proteins werebeing turned off).
While this is still in testing (and reported in the Public Library of Science Biology) if the trials prove conclusive, this kind of treatment could reduce surgery as well as chemotherapy in cancer patients.
The work is being done at the University of Calgary, Canada and funded jointly by the Province of Alberta Health Services.Stay tuned (as they say)